Non-Invasive Treatment Alternative will be Centerpiece to Expansion of Radiation Oncology Facility SUNNYVALE, Calif., July 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that St.
Major Academic Center Expands Cancer Treatment Access to Local Community SUNNYVALE, Calif., March 3 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that St. Louis University Hospital has purchased a second CyberKnife(R)
Innovative Radiation Therapy Device Enables Cancer Center to Provide Faster, Extremely Precise Radiation Treatments SUNNYVALE, Calif. , April 24, 2018 /PRNewswire/ -- Accuray Incorporated's (NASDAQ: ARAY) CyberKnife ® M6™ System with the InCise™ Multileaf Collimator (MLC) is enabling clinicians at
Install Marks the Fifth System in China and 121st CyberKnife System Installation SUNNYVALE, Calif, Nov. 27 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Hua Shan Hospital in Shanghai has installed a CyberKnife(R)
CyberKnife for Installation at Gyeongsang National University Hospital Will Expand Patient Access SUNNYVALE, Calif ., Aug. 12 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the Gyeongsang National University Hospital
Advanced, 10-Day Radiation Treatment Regimen Enables Patients to Get Back to Their Life, Faster SUNNYVALE, Calif. , Jan. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, phase II trial of 338 women with low-risk breast cancer showed 98.8
--Attendance Doubles with More Than 200 Health Professionals From 28 Countries Participating SUNNYVALE, Calif., April 10, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the second European
SUNNYVALE, Calif., May 9, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the U.S. Securities and Exchange Commission has declared effective the company's Form S-4 Registration Statement relating to the
Attendance Doubles with More Than 175 Health Professionals From 13 Countries Participating SUNNYVALE, Calif., May 5 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the Robotic Radiosurgery Course held on April 11 and
SUNNYVALE, Calif. , Feb. 1, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Robert C. Kill to the company's Board of Directors, effective as of January 30, 2023 . Mr. Kill is a skilled healthcare executive with more than 30 years' experience transforming
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.